Differences

This shows you the differences between two versions of the page.

--- content:acycarnitines [2020/02/16 17:55] – [Reference values] icna
+++ content:acycarnitines [2020/02/16 17:57] – [Notes] icna
@@ Line 4: / Line 4: @@
 suspected fatty acid oxidation disorders, acute myopathy, rhabdomyolysis, unexplained increased creatine kinase
 ==== Notes ====
-  * Diagnostic results are usually characterized by a pattern of significantly elevated acylcarnitine species compared to normal and disease controls.
+  * diagnostic results are usually characterized by a pattern of significantly elevated acylcarnitine species compared to normal and disease controls.
   * serum acylcarnitines are useful in the diagnosis of fatty acid oxidation disorders and several organic acidurias
   * serum acylcarnitines also useful in evaluating treatment during follow-up of patients with fatty acid beta-oxidation disorders and several organic acidurias
@@ Line 16: / Line 16: @@
 ==== Reference values ====
 <table refvalues>
-<caption>source: [[https://www.mayocliniclabs.com/test-catalog/Clinical+and+Interpretive/60644|Mayo Clinic Labs]]</caption>
+^                                      ^ 8 days-7 years  ^ > or =8 years  |             |
-^                                      ^ 8 days-7 years  | > or =8 years  |             |
 | < or =7 days (nmol/mL)               | (nmol/mL)       | (nmol/mL)      |             |
 | Acetylcarnitine, C2                  | 2.14-15.89      | 2.00-27.57     | 2.00-17.83  |
@@ Line 66: / Line 65: @@
 | 3-OH-octadecenoylcarnitine C18:1-OH  | <0.03           | <0.04          | <0.06       |
 | 3-OH-octadecanoylcarnitine, C18-OH   | <0.03           | <0.05          | <0.03       |
+<caption>source: [[https://www.mayocliniclabs.com/test-catalog/Clinical+and+Interpretive/60644|Mayo Clinic Labs]]</caption>
 </table>